GFAP and hematocrit: Immunostaining analysis and quantification of reactive gliosis using GFAP staining as a proxy showed that microglia and HT treatment induce lower and higher levels of reactive gliosis, respectively, compared to untreated controls, confirming earlier results (Figure 1), and gliosis upon treatment with microglia combined with HT was comparable to HT alone (Figure 4F).